Confirmed Exhibitors


Chiesi Limited is a family-owned company with a reputation for commitment to research and innovation. Our goal is to provide high quality, competitively priced medicines, designed to deliver best care for patients with a specific focus on respiratory disorders, rare diseases, special care and neonatology.

Chiesi aims to become a world leader in respiratory medicine and recent product innovations include the development of the NEXThaler® device, a novel dry powder inhaler with features designed to enhance patient experience for people living with asthma and Chronic Obstructive Pulmonary Disease (COPD).

Chiesi also works in special care and rare diseases with products for the management of chronic pulmonary infections in cystic fibrosis and the prevention and treatment of respiratory distress syndrome in premature neonates. In development are biologic therapies for rare, hereditary glycoprotein diseases that affect newborns and children and affect multiple systems in the body.

At Chiesi, we are passionate in our commitment to continually improving patient outcomes and in 2014 our investment in R&D provided a turnover in excess of 16% - one of the highest amongst the pharmaceutical industry. The Chiesi pipeline currently includes over 40 projects at various stages of development in respiratory, neonatology and several other rare diseases.


Gold Sponsors


POWERbreathe offers drug free, evidence based, breathing rehabilitation and respiratory training products.
Recognised as global leaders in breathing training technology developed by working closely with world leading Human Performance Scientists; Medical Practitioners; Electronic and Design Engineers, POWERbreathe have developed cutting edge products for professional and patient use.
POWERbreathe will be showcasing the electronic POWERbreathe K-series devices. The World’s 1st digital “Gold Standard” hand held respiratory muscle training (RMT/IMT), assessment and monitoring devices. The New KH2 device incl. Breathe-Link Medics s/w developed specifically for healthcare professionals will be available to demonstrate.
Also being presented, are the increasingly popular mechanical POWERbreathe Medic and Medic Plus (RMT / IMT) trainers. The NEW – POWERbreathe Shaker expiratory (PEP) mucus clearance devices, Shaker Classic; Shaker Deluxe; Shaker Medic, Shaker Medic Plus for respiratory care and breathing physiotherapy will be available to try.


At Teva, we help improve the health of over 200 million people every day. As the world’s largest generic medicines producer, we offer access to a medicine cabinet of more than 1,000 molecules, delivering a wide range of generic products to people in 100 countries. In specialty medicines, we have a world-leading position in several therapeutic areas, including the central nervous system and respiratory. We operate in 60 countries, producing 100 billion tablets every year. Our R&D pipeline, one of the richest in the industry, integrates generics and specialty capabilities to create new solutions for unmet patient needs, combining drug development with devices, services and technologies

Teva UK Ltd Logo

Leading the Way in Respiratory Medical Devices

The name Trudell Medical International (TMI) is synonymous with the development of innovative medical devices.

We are experts in designing and manufacturing the highest quality aerosol drug delivery and lung health devices for the management of respiratory conditions.

We supply the pharmaceutical and health care industry with branded and custom respiratory medical devices and solutions to help ease the burden that respiratory challenges bring to patients and their caregivers.

Ground Breaking Innovation

Our innovation focus is to develop products that improve patient outcomes and contribute to health system savings overall.

From the industry’s first-ever compact valved holding chamber and valved holding chamber developed for children, the first breath-actuated pneumatic nebulizer to our most recently launched award winning and clinically supported OPEP device.

These and other TMI ”firsts” play a fundamental role in enhancing therapeutic treatment outcomes for patients with asthma, COPD (Chronic Obstructive Pulmonary Disease) and other respiratory conditions.

Global Brand Recognition

Our best-in-class respiratory management products have been marketed in over 110 countries worldwide, with their efficacy validated in hundreds of peer reviewed articles.

Development Grounded in Science

Aerosol science is fundamental to the product development process at TMI, so much so that our corporate headquarters is home to an industry-leading aerosol research laboratory. The fully equipped, climate controlled laboratory has stringent aerosol testing protocols validated by pharmaceutical partners and industry associations. All our devices undergo rigorous design testing and verification.

Manufactured to the Highest Quality Standards
Design, development and manufacturing are located at the corporate headquarters in London,
Canada. Six sigma quality record with robust global compliance history and Global Medical Device registrations for Class I and II devices.

pfizer logo

Confirmed Charities

ARNS logo cmyk Large (6)
ARTP logo & strapline blue

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.

Get Flash Player